200 related articles for article (PubMed ID: 24661374)
1. Zinc monotherapy is effective in Wilson's disease patients with mild liver disease diagnosed in childhood: a retrospective study.
Ranucci G; Di Dato F; Spagnuolo MI; Vajro P; Iorio R
Orphanet J Rare Dis; 2014 Mar; 9():41. PubMed ID: 24661374
[TBL] [Abstract][Full Text] [Related]
2. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
Gupta P; Choksi M; Goel A; Zachariah U; Sajith KG; Ramachandran J; Chandy G; Kurian G; Rebekah G; Eapen CE
Indian J Gastroenterol; 2018 Jan; 37(1):31-38. PubMed ID: 29457214
[TBL] [Abstract][Full Text] [Related]
3. Combined sodium Dimercaptopropanesulfonate and zinc versus D-penicillamine as first-line therapy for neurological Wilson's disease.
Zhang J; Xiao L; Yang W
BMC Neurol; 2020 Jun; 20(1):255. PubMed ID: 32593295
[TBL] [Abstract][Full Text] [Related]
4. D-penicillamine versus zinc sulfate as first-line therapy for Wilson's disease.
Członkowska A; Litwin T; Karliński M; Dziezyc K; Chabik G; Czerska M
Eur J Neurol; 2014 Apr; 21(4):599-606. PubMed ID: 24447648
[TBL] [Abstract][Full Text] [Related]
5. [Wilson disease: an update].
Seo JK
Korean J Hepatol; 2006 Sep; 12(3):333-63. PubMed ID: 16998287
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of Wilson's disease with penicillamine and zinc salts: a follow-up study].
Li M; Zhang YH; Qin J
Zhonghua Er Ke Za Zhi; 2003 Feb; 41(2):119-22. PubMed ID: 14759316
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal side effects in children with Wilson's disease treated with zinc sulphate.
Wiernicka A; Jańczyk W; Dądalski M; Avsar Y; Schmidt H; Socha P
World J Gastroenterol; 2013 Jul; 19(27):4356-62. PubMed ID: 23885147
[TBL] [Abstract][Full Text] [Related]
8. Combined dimercaptosuccinic acid and zinc treatment in neurological Wilson's disease patients with penicillamine-induced allergy or early neurological deterioration.
Zhu XQ; Li LY; Yang WM; Wang Y
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32809015
[TBL] [Abstract][Full Text] [Related]
9. Serum transaminases in children with Wilson's disease.
Iorio R; D'Ambrosi M; Marcellini M; Barbera C; Maggiore G; Zancan L; Giacchino R; Vajro P; Marazzi MG; Francavilla R; Michielutti F; Resti M; Frediani T; Pastore M; Mazzarella G; Fusco G; Cirillo F; Vegnente A;
J Pediatr Gastroenterol Nutr; 2004 Oct; 39(4):331-6. PubMed ID: 15448420
[TBL] [Abstract][Full Text] [Related]
10. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study.
Merle U; Schaefer M; Ferenci P; Stremmel W
Gut; 2007 Jan; 56(1):115-20. PubMed ID: 16709660
[TBL] [Abstract][Full Text] [Related]
11. Wilson's disease: long-term follow-up of a cohort of 24 patients treated with D-penicillamine.
Lowette KF; Desmet K; Witters P; Laleman W; Verslype C; Nevens F; Fevery J; Cassiman DM
Eur J Gastroenterol Hepatol; 2010 May; 22(5):564-71. PubMed ID: 20042865
[TBL] [Abstract][Full Text] [Related]
12. Subclinical neurological involvement does not develop if Wilson's disease is treated early.
Dubbioso R; Ranucci G; Esposito M; Di Dato F; Topa A; Quarantelli M; Matarazzo M; Santoro L; Manganelli F; Iorio R
Parkinsonism Relat Disord; 2016 Mar; 24():15-9. PubMed ID: 26851839
[TBL] [Abstract][Full Text] [Related]
13. Practical recommendations and new therapies for Wilson's disease.
Brewer GJ
Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
[TBL] [Abstract][Full Text] [Related]
14. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
Sinha S; Taly AB
J Neurol Sci; 2008 Jan; 264(1-2):129-32. PubMed ID: 17765927
[TBL] [Abstract][Full Text] [Related]
15. Spatial investigation of the elemental distribution in Wilson's disease liver after d-penicillamine treatment by LA-ICP-MS.
Hachmöller O; Zibert A; Zischka H; Sperling M; Groba SR; Grünewald I; Wardelmann E; Schmidt HH; Karst U
J Trace Elem Med Biol; 2017 Dec; 44():26-31. PubMed ID: 28965585
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
Schilsky ML
Curr Gastroenterol Rep; 2001 Feb; 3(1):54-9. PubMed ID: 11177695
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
18. Adverse Events with D-penicillamine Therapy in Hepatic Wilson's Disease: A Single-Center Retrospective Audit.
Kumar S; Patra BR; Irtaza M; Rao PK; Giri S; Darak H; Gopan A; Kale A; Shukla A
Clin Drug Investig; 2022 Feb; 42(2):177-184. PubMed ID: 35102516
[TBL] [Abstract][Full Text] [Related]
19. Wilson's disease: A 2017 update.
Poujois A; Woimant F
Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):512-520. PubMed ID: 29625923
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation.
Bruha R; Marecek Z; Pospisilova L; Nevsimalova S; Vitek L; Martasek P; Nevoral J; Petrtyl J; Urbanek P; Jiraskova A; Ferenci P
Liver Int; 2011 Jan; 31(1):83-91. PubMed ID: 20958917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
